Literature DB >> 25999448

Impact of hospital volume on outcomes of patients undergoing chemotherapy for acute myeloid leukemia: a matched cohort study.

Smith Giri1, Ranjan Pathak2, Madan Raj Aryal2, Paras Karmacharya2, Vijaya Raj Bhatt3, Mike G Martin4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25999448     DOI： 10.1182/blood-2015-01-625764

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  22 in total

1.  Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma.

Authors:  Scott F Huntington; Jessica R Hoag; Weiwei Zhu; Rong Wang; Amer M Zeidan; Smith Giri; Nikolai A Podoltsev; Steven D Gore; Xiaomei Ma; Cary P Gross; Amy J Davidoff
Journal:  Cancer       Date:  2018-09-14       Impact factor: 6.860

2.  The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900).

Authors:  Bruno C Medeiros; Megan Othus; Martin S Tallman; Zhuoxin Sun; Hugo F Fernandez; Jacob M Rowe; Hillard M Lazarus; Frederick R Appelbaum; Selina M Luger; Mark R Litzow; Harry P Erba
Journal:  Leuk Res       Date:  2019-01-17       Impact factor: 3.156

3.  Understanding the Relationship Between Care Volume and Clinical Outcomes in Multiple Myeloma.

Authors:  Ethan A Halm; Larry D Anderson; David E Gerber
Journal:  J Clin Oncol       Date:  2017-01-17       Impact factor: 44.544

4.  Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States.

Authors:  Amer M Zeidan; Nikolai A Podoltsev; Xiaoyi Wang; Chi Zhang; Jan Philipp Bewersdorf; Rory M Shallis; Scott F Huntington; Natalia Neparidze; Smith Giri; Steven D Gore; Amy J Davidoff; Xiaomei Ma; Rong Wang
Journal:  Blood Adv       Date:  2020-04-28

Review 5.  Exploring Big Data in Hematological Malignancies: Challenges and Opportunities.

Authors:  Gustavo F Westin; Ajoy L Dias; Ronald S Go
Journal:  Curr Hematol Malig Rep       Date:  2016-08       Impact factor: 3.952

6.  Antifungal prophylaxis during 7 + 3 induction chemotherapy for acute myeloid leukemia is associated with improved survival, in a setting with low incidence of invasive mold infections.

Authors:  Andrew Hsu; Robert Matera; Kendra Vieira; John L Reagan; Dimitrios Farmakiotis
Journal:  Support Care Cancer       Date:  2020-05-21       Impact factor: 3.603

7.  Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia.

Authors:  Gwendolyn Ho; Brian A Jonas; Qian Li; Ann Brunson; Ted Wun; Theresa H M Keegan
Journal:  Br J Haematol       Date:  2017-04-17       Impact factor: 6.998

8.  Association Between Treatment at High-Volume Facilities and Improved Overall Survival in Soft Tissue Sarcomas.

Authors:  Sriram Venigalla; Kevin T Nead; Ronnie Sebro; David M Guttmann; Sonam Sharma; Charles B Simone; William P Levin; Robert J Wilson; Kristy L Weber; Jacob E Shabason
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-12-21       Impact factor: 7.038

9.  Association of Risk Factors, Mortality, and Care Costs of Adults With Acute Myeloid Leukemia With Admission to the Intensive Care Unit.

Authors:  Anna B Halpern; Eva Culakova; Roland B Walter; Gary H Lyman
Journal:  JAMA Oncol       Date:  2017-03-01       Impact factor: 31.777

10.  Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California.

Authors:  Gwendolyn Ho; Ted Wun; Lori Muffly; Qian Li; Ann Brunson; Aaron S Rosenberg; Brian A Jonas; Theresa H M Keegan
Journal:  Cancer       Date:  2018-02-16       Impact factor: 6.921
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.